Skip to content

DR. VAN DE WALLE PETER

Active
Private limited companyfounded 2001active for 25 yearsStokstraat 58, 9340 Lede, BelgiumKBO/BCE: BE 0475.273.670
Summary

For DR. VAN DE WALLE PETER, at least two annual filings are missing. The 2023 annual accounts show equity of €385,449 and a net result of €41,120. Equity has been shrinking by about 7.6% per year since 2019. Its solvency ranks better than 36% of 591 sector peers (NACE 72, financial year 2023). The company has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.0% (low).

DR. VAN DE WALLE PETERActive

Overview

Official details

Source: KBO
Status
Active since 12-07-2001 Normal situation
Activity
Research and development on biotechnology NACE 72101and 1 other
Establishment unit
2.210.748.675 9340 Lede, since 06-07-2001
Financial year end
31 March
Peppol
Reachable since 01-12-2025

Board and ownership

Board

Financial position

Bankruptcy probabilitywithin 12 months
1.0%
2023 figures too old to score
Annual accounts to 31-03-2023
Gross margin
€146,291
▲ 29.4%
Turnover
≈ €370,000
estimated
Profit
€41,120
▲ 8.0%
Equity
€385,449
▲ 11.9%
Total assets
€812,698
▲ 7.5%
Employees on 31-03-2023
1
=
  • 2024 accounts not filed, 732 days past the deadline
Filed on 30-11-2023
Signalsraises riskFigures for financial year 2023 (filed on 01-12-2023)3 financial years not filed after the legal deadline; last filed accounts filed 30 days lateTwo or more financial years not filed2023 accounts filed 30 days latelowers riskLiquidity: current ratio 11.09, cash €391,532Sector: Scientific research and development (NACE 72)Show the evidence

Bankruptcy probability

No current score
Figures too old
The latest figures are for FY 2023. They are too old for a current score.
Filing: At least two annual filings are missing
Financial strength, FY 2023 · tick: 2022
Strong
Solvency 72+1
equity 47.4% of total assets
Liquidity 100+7
short-term debt 8.3% · cash 48.2%
Profitability 75+12
return on assets 5.1%
Bankruptcy probability within 12 months
1.0% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (935 companies, NACE 72, micro)
Last 24 months 12-2024: 0.1%lowest value 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.2%▲ +0.1 percentage points vs 02-2025 04-2025: 0.5%▲ +0.3 percentage points vs 03-2025 05-2025: 0.5%● unchanged vs 04-2025 06-2025: 0.5%● unchanged vs 05-2025 07-2025: 0.4%▼ -0.1 percentage points vs 06-2025 08-2025: 0.4%● unchanged vs 07-2025 09-2025: 0.4%● unchanged vs 08-2025 10-2025: 0.4%● unchanged vs 09-2025 11-2025: 0.8%▲ +0.4 percentage points vs 10-2025 12-2025: 0.8%● unchanged vs 11-2025 01-2026: 1.0%▲ +0.2 percentage points vs 12-2025highest value 02-2026: 1.0%● unchanged vs 01-2026highest value 03-2026: 1.0%● unchanged vs 02-2026highest value 04-2026: 1.0%● unchanged vs 03-2026highest value 05-2026: 1.0%● unchanged vs 04-2026highest value 06-2026: 1.0%● unchanged vs 05-2026highest value 07-2026: 1.0%● unchanged vs 06-2026highest value 08-2026: 1.0%● unchanged vs 07-2026highest value 09-2026: 1.0%● unchanged vs 08-2026highest value 10-2026: 1.0%● unchanged vs 09-2026 11-2026: 1.0%● unchanged vs 10-2026
Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
raises risk · Figures for financial year 2023 (filed on 01-12-2023)
NBB · annual accounts
raises risk · 3 financial years not filed after the legal deadline; last filed accounts filed 30 days late
NBB · filings
lowers risk · Liquidity: current ratio 11.09, cash €391,532
NBB · annual accounts
lowers risk · Sector: Scientific research and development (NACE 72)
KBO
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-03-2024, 3 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 10 filings
Position against the passed deadline
31-03-2024 year end31-10-2024 deadline02-11-2026 today
raises risk · 2023 accounts filed 30 days late
The financial year that closed on 31-03-2023 was due by 31-10-2023 and was filed on 30-11-2023, 30 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2026
not filed
2025
not filed
2024
not filed
2023
30 days late
2022
24 days late
2021
30 days late
2020
27 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 28 days after the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Recent changes

  1. · Gazette deed Change of role: Peter VAN DE WALLE, from statutory director to director
  2. · Gazette deed Incorporation
All 14 events

Comparable companies

These companies have the same main activity as DR. VAN DE WALLE PETER: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €659,000 and €1m, founded between 2000 and 2005.

CompanyTotal assetsGross margin
DR. VAN DE WALLE PETER Lede€0.8m€0.1m
DOKTER SCHOCKAERT Gent€0.8m€0.2m
DOKTER JOZEF VULSTEKE Ieper€0.8m€0.2m
RHUMAT-OS Waterloo€0.7m€0.2m
EMES INTERNATIONAL RESEARCH NETWORK Liège€0.7m€0.2m
AB PSY DINANT Dinant€1.0m€0.2m
Dokter Dirk HENDRICK Gent€0.9m€0.2m
Full comparison

Key facts about DR. VAN DE WALLE PETER

What is the company number of DR. VAN DE WALLE PETER?
The company number of DR. VAN DE WALLE PETER is 0475.273.670. The VAT number is the same number with BE in front: BE 0475.273.670.
Where is DR. VAN DE WALLE PETER based?
The registered office is at Stokstraat 58, 9340 Lede.Company details
What does DR. VAN DE WALLE PETER do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of DR. VAN DE WALLE PETER?
The legal form of DR. VAN DE WALLE PETER is Private limited company (BV).
When was DR. VAN DE WALLE PETER founded?
DR. VAN DE WALLE PETER was founded on 12-07-2001.
Is DR. VAN DE WALLE PETER still active?
Yes, DR. VAN DE WALLE PETER is an active enterprise in the KBO register.
How many employees does DR. VAN DE WALLE PETER have?
DR. VAN DE WALLE PETER had an average of 1 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
What is the turnover of DR. VAN DE WALLE PETER?
The turnover in financial year 2023 is ≈ €370,000. This figure is estimated from the gross margin of €146,291 and 2,211 comparable companies of the same size. It probably lies between €240,000 and €570,000. It is a rough estimate.
Is DR. VAN DE WALLE PETER profitable?
In financial year 2023, DR. VAN DE WALLE PETER made a profit of €41,120.
Where can I find the annual accounts of DR. VAN DE WALLE PETER?
DR. VAN DE WALLE PETER filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2023.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.